SimBioSys Secures Third FDA Clearance for TumorSight™ Viz, Advancing AI-Powered Precision Surgery in Breast Cancer Care

Latest release introduces industry-leading AI performance, optimized workflow integration, and enhanced surgeon usability to streamline imaging-to-intervention planning CHICAGO, July 9, 2025 /PRNewswire/ -- SimBioSys®, a clinical AI company leveraging spatial biophysics to drive precision...